A Swedish study within the European Platform for Neurodegenerative Diseases (EPND) aiming to identify new biomarkers in dementia

A Swedish, prospective, observational case study within the European Platform for Neurodegenerative Diseases (EPND) aiming to identify new biomarkers in dementia

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN15882931

Enrollment

300

Registered

2026-06-01

Start date

2025-10-27

Completion date

Unknown

Last updated

2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive decline Mental and Behavioural Disorders

Interventions

The enriched dataset will comprise comprehensive fluid, neuroimaging and digital biomarkers aiming to improve diagnosis and molecular characterization of the earliest stages of Alzheimer’s disease and

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Research participants who consented to the memory clinic database at Karolinska University Hospital (GEDOC) and who speak and read Swedish

Exclusion criteria

Exclusion criteria: 1. Moderate dementia and severe dementia, as determined by Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) 2. Severe visual or communication impairment 3. Conditions that prevent cooperation/participation as determined by the physician 4. A serious illness (e.g., cancer, severe psychiatric/neurological illness [in addition to Alzheimer's disease (AD)]), as determined by the physician's clinical judgment 5. Withdrawn consent to the GEDOC and/or EPND study

Countries

Sweden

Contacts

Public ContactJohan Lundberg

gedoc.karolinska@regionstockholm.se+46 (0)812370000

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jun 21, 2026